# Mixlab

> Mixlab is a modern veterinary compounding pharmacy that pairs a digital prescribing platform with custom-made, flavored pet medications delivered to the home. Founded in 2017 in New York, it lets veterinarians write and approve prescriptions in seconds while pet owners skip the clinic pickup and the spit-out pill. Mixlab compounds species-specific formulations for dogs, cats, horses, exotics and zoo animals, and in 2026 introduced Maisy, an AI health partner built on its first-party pharmacy data.

- **Founded:** 2017
- **Headquarters:** New York, United States
- **Founders:** Frederic Dijols (Co-founder & CEO), Stella Kim (Co-founder & Chief Experience Officer)
- **Team size:** ~160 employees
- **Products:** Veterinary compounding pharmacy, eMix prescribing platform, Home delivery, Browsable shopping experience, Maisy AI health partner
- **Notable:** Grew prescriber network to more than 30,000 in 2025, more than doubling year over year, Supported care for over 140,000 animals in 2025 (~75% growth), Expanded to five compounding labs across New York, California, Florida, Texas and Wisconsin

## Products & services

- **Veterinary compounding pharmacy** — PCAB-accredited compounding of custom, species-specific medications - flavored chews, transdermal gels, liquids and tailored dosages for dogs, cats, horses, exotics and zoo animals.
- **eMix prescribing platform** — Web platform that lets veterinarians write, review and approve prescriptions in seconds, track compliance, and integrate with veterinary systems like Vetcove, Vetsource and Instinct EMR.
- **Home delivery** — Fast, free shipping of pet medications to the owner's door, with same-day delivery in select markets near Mixlab's labs.
- **Browsable shopping experience** — A direct-to-consumer storefront with a prescription request workflow that integrates with eMix for one-click vet approval.
- **Maisy AI health partner** — AI assistant launched in 2026 that uses Mixlab's first-party data and prescribing infrastructure to answer medication questions, reinforce compliance and provide proactive support for vets and pet owners.

## Achievements

- Grew prescriber network to more than 30,000 in 2025, more than doubling year over year
- Supported care for over 140,000 animals in 2025 (~75% growth)
- Expanded to five compounding labs across New York, California, Florida, Texas and Wisconsin
- PCAB-accredited compounding pharmacy
- Raised $46.5M in total funding
- Launched Maisy, an AI health partner, in January 2026
- Completed three acquisitions (NexGen Animal Health, The Pet Apothecary, SBH veterinary business) to expand species coverage and geography

## Latest updates

- **2026-01** — Unveiled Maisy, an AI health partner built on Mixlab's first-party pharmacy data to support medication adherence and answer common questions.
- **2025-12** — Closed a year of rapid growth: 30,000+ prescribers and 140,000+ animals supported; deepened integrations with Vetcove, Vetsource and Instinct EMR.
- **2025-01** — Acquired The Pet Apothecary (Wisconsin) and SBH Medical's veterinary business (Ohio), adding a Milwaukee lab and tripling its Midwest partner network.
- **2024-05** — Acquired NexGen Animal Health to expand compounding into large animals such as horses.
- **2023-08** — Raised $10M led by Vanterra Ventures with PLUS Capital to enhance its platform and expand nationwide.

## Links

- Website: https://mixlab.com
- LinkedIn: https://www.linkedin.com/company/mixlabrx
- Twitter/X: https://twitter.com/mixlabrx
- Instagram: https://www.instagram.com/mixlabrx/
- Facebook: https://www.facebook.com/mixlabrx/

---

Profile page: https://yespress.io/mixlab
Published by YesPress — https://yespress.io
Last updated: 2026-06-13